BioStem Technologies Operating Expenses Growth & History (BSEM)
BioStem Technologies's operating expenses was $45.1M for fiscal 2025.
View full BioStem Technologies company overviewBioStem Technologies annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $45.1M | $20.3M | +82.03% |
| 2024 | 2024-12-31 | $24.8M | $1.6M | +6.84% |
| 2023 | 2023-12-31 | $23.2M | $12.5M | +117.37% |
| 2022 | 2022-12-31 | $10.7M | $6.2M | +138.72% |
| 2021 | 2021-12-31 | $4.5M | — | — |
BioStem Technologies quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $13.2M | $3.1M | +30.26% |
| Q1 2026 | 2026-03-31 | $12.7M | −$51.2M | −80.15% |
| Q3 2025 | 2025-09-30 | $7.8M | — | — |
| Q2 2025 | 2025-06-30 | $10.2M | — | — |
| Q1 2025 | 2025-03-31 | $63.9M | — | — |
| Q4 2024 | 2024-12-31 | $90.9M | — | — |
BioStem Technologies operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, BioStem Technologies's operating expenses increased from $4.5M to $45.1M, a change of $40.7M. The latest reported quarter, Q2 2026, shows $13.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioStem Technologies source filings ↗